F.A.Q.
Sign in
0 Product Products (empty)

No products

€0.00 Total

Check out

Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products
Continue shopping Proceed to checkout
Sciva International s.r.o.
Menu
  • Home
  • E-SHOP
    • CBD oils
    • Capsules
      • Veterinary products
      • Wellness products
      • Cosmetic products
    • About us
    • RESEARCH DATA
      • ANXIETY
      • ALZHEIMER´S
      • ADDICTION
      • ADD/ADHD
      • AIDS
      • ALS
      • ANOREXIA
      • ANTIBIOTIC RESISTANCE
      • ARTHRITIS
      • ATHEROSCLEROSIS
      • ASTHMA
      • AUTISM
      • BIPOLAR
      • CANCER STUDIES
      • CHRONS AND STOMACH PROBLEMS
      • DEPRESSION
      • DIABETES
      • ENDOCRINE DISORDERS
      • EPILEPSY/SEIZURE
      • FIBRYOMALGI
      • GLAUCOMA
      • HEART DISEASE
      • HUNTINGTON´S
      • INFLAMATIONS
      • IRRITABLE BOWEL SYNDROM
      • KIDNEY DISEASE
      • LIVER DISEASE
      • METABOLIC SYNDROME
      • MIGRAINE
      • MOOD DISORDERS
      • MOTION SICKNESS
      • MS/MULTIPLE SCLEROSIS
      • NAUSEA
      • NEURODEGENERATION
      • NEUROPATHIC PAIN
      • OBESITY
      • OCD
      • OSTEOPOROSIS
      • PARKINSON DISEASE
      • PRION/MAD COW DISEASE
      • PTSD
      • RHEUMATISM
      • SCHIZOPHRENIA
      • SICKLE CELL ANEMIA
      • SKIN CODITION
      • SLEEP DISORDERS
      • SPINAL CORD INJURY
      • STRESS
      • STROKE/TBI
    • Blog
    • Testimonials
    • Contact
    / RESEARCH DATA/ PARKINSON DISEASE

    Prospects for cannabinoid therapies in basal ganglia disorders (PubMed)

    Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties (PubMed)

    Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease (PubMed)

    Cannabidiol can improve complex sleep-related behaviours associated with rapideye movement sleep behaviour disorder in Parkinson’s disease patients: a caseseries (PubMed)

    Cannabidiol for the treatment of psychosis in Parkinson’s disease (PubMed)

    Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease (PubMed)

    Therapeutic potential of cannabinoids in CNS disease (PubMed)

    Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial. (PubMed 2014)

    Dorsolateral Prefrontal Cortex N-Acetylaspartate/Total Creatine (NAA/tCr) Loss in Male Recreational Cannabis Users (Research Gate/PubMed 2007)

    Cannabidiol for the treatment of psychosis in Parkinson’s disease. (PubMed 2008)


    Stay connected

    • Facebook
    • Youtube
    • Instagram

    Our website processes cookies in order to increase the user-friendliness of the website and, in the case of your consent, to personalize ads. More info

    close

    Disclaimer

    This website is an initiative of the company Sciva International s.r.o., which has its head office in Prague, the Czech Republic.

    Sciva International s.r.o. shall not be held liable for the medical claims made by customers. It should be noted that these products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care professionals. Sciva International s.r.o. does not make any health claims about our products except those officially approved by EFSA and recommends consulting with health care professionals prior to consuming our products. It is especially important for those who are pregnant, nursing, chronically ill, elderly to discuss the use of these products with health care professionals. You must be 18 years or older to visit this website and/or purchase the products. The website may contain references in the form of hyperlinks, banners or buttons for example, to third party websites. Sciva International s.r.o. has no authority over these websites. The rights relating to this website, including those of intellectual ownership, copyright on text, streaming videos, images, design, data files, photographs and other (moving or stationary) visual material, audio material, formats, software, brands (including domain names) and other material are held by Sciva International s.r.o. and/or its licensing body.

    © 2023 Sciva Corporation s.r.o. All Rights Reserved.



    Cookies Consent to processing of personal data

    © 2023 Sciva Corporation s.r.o. All Rights Reserved.

    Are you more than
    18 years of age?

    Yes No